PainReform: Funding, Investors & Team (Sep 2026)
PainReform is a company specializing in pharmaceuticals aimed at finding solutions for pain treatment. Their primary focus is on improving existing pain medications for the US FDA 505(b)(2) regulatory pathway. PainReform utilizes innovative technologies to make these drugs more effective, decrease negative side effects, and make them more convenient for patients. Additionally, they aim to expedite the recovery of motor function.
PainReform has raised $5.3M across 2 funding rounds on record, the most recent an undisclosed round of $4.0M announced in Apr 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PainReform Company Profile and Key Stats
Latest funding round on record: Apr 2024.
PainReform Funding Rounds
PainReform raised $1.3M in an undisclosed round announced in Dec 2023.
4 months later, an undisclosed round of $4.0M was announced in Apr 2024.
PainReform Founders and Leadership Team
No contact details are on record for this team yet.
PainReform Funding Compared to Other Biotechnology Startups
PainReform's latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PainReform in Biotechnology and Herzliya
Companies Similar to PainReform
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
PainReform Funding FAQs
What does PainReform do?
PainReform is a company specializing in pharmaceuticals aimed at finding solutions for pain treatment. Their primary focus is on improving existing pain medications for the US FDA 505(b)(2) regulatory pathway. PainReform utilizes innovative technologies to make these drugs more effective, decrease negative side effects, and make them more convenient for patients. Additionally, they aim to expedite the recovery of motor function.
How much funding has PainReform raised?
PainReform has raised $5.3M across 2 rounds on record. The most recent is an undisclosed round of $4.0M announced in Apr 2024.
When did PainReform last raise funding?
PainReform's most recent funding round on record is an undisclosed round of $4.0M, announced in Apr 2024.
Who founded PainReform?
FundedIQ lists Michael Mulholland (Founder) at PainReform.
Where is PainReform headquartered?
PainReform is based in Herzliya, Tel Aviv, Israel.
How many employees does PainReform have?
PainReform is in the 1-10 employee band.
How does PainReform's funding compare to other Biotechnology startups?
PainReform's latest round of $4.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's PainReform Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PainReform is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.